Vol. 4 — July-August 2013

• Calcimimetics and other simple pharmacological interventions do not work in dialysis: what can we do about it?
  

  Suetonia C. Palmer^1,2, Giovanni F.M. Strippoli^2,3,4,5,6

  (1) Department of Medicine, University of Otago Christchurch, Christchurch - New Zealand
  (2) Cochrane Renal Group, Sydney - Australia
  (3) Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Province of Chieti - Italy
  (4) School of Public Health, University of Sydney, Sydney - Australia
  (5) Department of Emergency and Organ Transplantation, University of Bari, Bari - Italy
  (6) Diaverum Medical Scientific Office, Lund - Sweden

• Anticoagulation and kidney injury: rare observation or common problem?
  

  Ian R. Logan¹, Neil S. Sheerin¹

  (1) Newcastle University, Newcastle Upon Tyne - UK

• Cardiac valve calcification: an immutable pathologic finding in chronic kidney disease?
  

  Antonio Bellasi¹, Andrea Galassi², Sergio Papagni³, Mario Cozzolino⁴

  (1) Department of Nephrology, Ospedale Sant’Anna-Como, Como - Italy
  (2) Department of Nephrology, Azienda di Desio e Vimercate, Desio - Italy
  (3) Division of Nephrology, Centro Dialisi CBH-Città di Bisceglie, Bisceglie - Italy
  (4) Department of Health Sciences, University of Milan, Milan - Italy

• Urinary proteome in a snapshot: normal urine and glomerulonephritis
  

  Laura Santucci¹, Giovanni Candiano¹, Maurizio Bruschi¹, Monica Bodria², Corrado Murtas¹, Andrea Petretto³, Gian Marco Ghiggeri¹

  (1) Nephrology, Dialysis, Transplantation Unit and Laboratory of the Pathophysiology of Uremia, Giannina Gaslini Institute, Genoa - Italy
  (2) Division of Nephrology, Department of Internal Medicine, University of Genoa, Genoa - Italy
  (3) Mass Spectrometry Core Facility and Laboratory of Molecular Medicine, Giannina Gaslini Institute, Genoa - Italy

• The epidemiology of atrial fibrillation in 
end-stage renal disease
  

  Panagiotis Korantzopoulos¹, Tong Liu², Konstantinos P. Letsas³, Nikolaos Fragakis⁴, Konstantinos Kyrlas¹, John A. Goudevenos¹

  (1) Department of Cardiology, University of Ioannina Medical School, Ioannina - Greece
  (2) Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin - PR China
  (3) Second Department of Cardiology, Evangelismos ?General Hospital, Athens - Greece
  (4) Third Cardiology Department, Hippokration Hospital, Aristotle University Medical School, Thessaloniki - Greece

• Managing new-onset gout in pediatric renal transplant recipients: when, how, to what extent
  

  Farahnak Assadi¹

  (1) Section of Nephrology, Department of Pediatrics, Rush University Medical Center, Chicago, Illinois - USA

• Management of hyperglycemia in patients with chronic kidney disease
  

  Patrícia Aires Neto¹, Henrique Vieira Gomes¹, Mário Campos¹

  (1) Nephrology Department, Coimbra University Hospitals, Coimbra - Portugal

• Vitamin D metabolism and activity as well as genetic variants of the vitamin D receptor (VDR) in chronic kidney disease
  

  Domenico Santoro¹, Daniela Caccamo², Giorgia Gagliostro¹, Riccardo Ientile², Salvatore Benvenga³, Guido Bellinghieri¹, Vincenzo Savica¹

  (1) Units of Nephrology and Dialysis, Clinical Experimental Department of Medicine and Pharmacology, University of Messina, Messina - Italy
  (2) Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, Messina - Italy
  (3) Interdepartmental Program of Molecular and Clinical Endocrinology and Women’s Endocrine Health, University of Messina, Messina - Italy

• Kidney transplantation and enzyme replacement therapy in patients with Fabry disease
  

  Markus Cybulla¹, Christine Kurschat², Michael West³, Kathy Nicholls⁴, Joan Torras⁵, Gere Sunder-Plassmann⁶, Sandro Feriozzi⁷

  (1) FGM, Center of Internal Medicine, Department of Nephrology and Rheumatology, Müllheim - Germany
  (2) Renal Division, Department of Medicine, University of Cologne, Cologne - Germany
  (3) Department of Medicine, Dalhousie University, Halifax - Canada
  (4) Department of Medicine, Royal Melbourne Hospital, Victoria - Australia
  (5) Department of Nephrology, Hospital of Bellvitge, IDIBELL University of Barcelona, Barcelona - Spain
  (6) Department of Nephrology, Medical University, Vienna - Austria
  (7) Department of Nephrology, Belcolle Hospital, Viterbo - Italy

• Further insights about the beneficial effects of n-3 fatty acids in the early molecular events of renal fibrosis in vitr
  

  Giovanna Priante¹, Estella Musacchio², Chiara Valvason¹, Giulio Clari³, Luciana Bordin³, Leonardo Sartori², Bruno Baggio¹

  (1) Nephrology Unit, Department of Medicine DIMED, University of Padova, Padova - Italy
  (2) Clinica Medica I, Department of Medicine DIMED, University of Padova, Padova - Italy
  (3) Department of Molecular Medicine, University of Padova, Padova - Italy

• Losartan preserves glomerular basement membrane anionic charge sites in a rat model of nephropathy
  

  Yan Liu¹, Daoyuan Zhou¹, Xiao Xiao¹, Danping Qin¹, Xiaoshi Zhong¹, Xuan Xiong¹, Kiyoko Inui², Ashio Yoshimura²

  (1) Department of Nephrology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou - PR China
  (2) Division of Nephrology, Department of Medicine, Fujigaoka Hospital of Showa University, Yokohama City - Japan

• Angiopoietin-2 modulates eEOC-mediated renoprotection in AKI in a dose-dependent manner
  

  Daniel Patschan¹, Rico Backhaus¹, Hans-Jörg Elle¹, Katrin Schwarze¹, Elvira Henze¹, Jan Ulrich Becker², Susann Patschan¹, Gerhard Anton Müller¹

  (1) Department of Nephrology and Rheumatology, University Hospital of Göttingen, Göttingen - Germany
  (2) Department of Pathology, Medical School Hannover, Hannover - Germany

• Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular
  

  Nicolas R. Robles¹, Francisco J. Felix², Daniel Fernandez-Berges^3,4,5, Jose F. Perez-Castán⁴, Maria J. Zaro⁶, Luis Lozano⁷, Paula Alvarez-Palacios³, Antonio Garcia-Trigo³, Veronica Tejero³, Yolanda Morcillo³, Ana B. Hidalgo³

  (1) Cardiovascular Risk Chair, University of Salamanca, Salamanca - Spain
  (2) Health Center Villanueva de la Serena, Badajoz - Spain
  (3) Research Unit Don Benito-Villanueva de la Serena, Cardiovascular Diseases Research Unit, FUNDESALUD, Badajoz - Spain
  (4) Health Area Management, Don Benito-Villanueva de la Serena, Badajoz - Spain
  (5) and Hospital of Don Benito-Villanueva de la Serena, Badajoz - Spain
  (6) Hospital of Don Benito-Villanueva de la Serena, Badajoz - Spain
  (7) Health Center Merida, Badajoz - Spain

• Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features
  

  Gang Xin¹, Wei Shi², Li-Xia Xu², Yun Su¹, Li-Jun Yan³, Kang-Sheng Li¹

  (1) Department of Microbiology and Immunology, Key Immunopathology Laboratory of Guangdong Province, Shantou University Medical College, Shantou, Guangdong - PR China
  (2) Department of Nephrology, Guangdong General Hospital, Guangzhou, Guangdong - PR China
  (3) Department of Nephrology, First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong - PR China

• Overanticoagulation is associated with renal function decline
  

  Jan Cornelis van Blijderveen¹, Katia M. Verhamme², Robert Zietse³, Loes E. Visser^1,4,5, Silvana A. Romio², Peter N. Buhre⁶, Miriam C. Sturkenboom^1,2, Albert Hofman¹, Sabine M. Straus^2,7, Bruno H. Stricker^2,8

  (1) Department of Epidemiology, Erasmus Medical Center, Rotterdam - The Netherlands
  (2) Department of Medical Informatics, Erasmus Medical Center, Rotterdam - The Netherlands
  (3) Department of Internal Medicine, Erasmus Medical ?Center, Rotterdam - The Netherlands
  (4) Department of Internal Medicine, Erasmus Medical Center, Rotterdam - The Netherlands
  (5) Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam - The Netherlands
  (6) Star Medical Diagnostic Center, Rotterdam - The ?Netherlands
  (7) Dutch Medicines Evaluation Board, Utrecht - The ?Netherlands
  (8) Drug Safety Unit, Inspectorate of Healthcare, The ?Hague - The Netherlands

• Twenty-three-year review of disease patterns from renal biopsies: an experience from a pediatric renal center
  

  Xiao-Ling Yin¹, Min-Shu Zou², Yu Zhang¹, Jia Wang¹, Tong-Lin Liu¹, Jin-Hui Tang¹, Li-Ru Qiu¹, Yu Chen¹, Hui-Qing Yuan¹, Jian-Hua Zhou¹

  (1) Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province - PR China
  (2) Department of Pediatrics, Wuhan General Hospital of Guangzhou Command, Wuhan, Hubei Province - PR China

• Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy
  

  Hiyori Suzuki¹, Isao Ohsawa¹, Fumiko Kodama¹, Kazutaka Nakayama¹, Atsuko Ohtani¹, Kisara Onda¹, Seiji Nagamachi¹, Atsushi Kurusu¹, Yusuke Suzuki¹, Hiroyuki Ohi², Satoshi Horikoshi¹, Yasuhiko Tomino¹

  (1) Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo - Japan
  (2) Department of Internal Medicine, Tsurumi-Nishiguchi Hospital, Tokyo - Japan

• Performance of creatinine-based equations compared in older patients
  

  Laetitia Koppe¹, Amna Klich², Laurence Dubourg³, René Ecochard², Aoumeur Hadj-Aissa³

  (1) Nephrology Department, Hospital E. Herriot, HCL, ?Lyon - France
  (2) Biostatistic Unit, HCL, Lyon - France
  (3) Renal Functional Exploration Department, Hospital E. Herriot, HCL, Lyon - France

• Microalbuminuria can predict the development of acute kidney injury in critically ill septic patients
  

  Zhongheng Zhang¹, Baolong Lu¹, Hongying Ni¹, Xiaoyan Sheng¹, Ni Jin¹

  (1) Department of Critical Care Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang Province - PR China

• Genome-wide analysis of long noncoding RNA expression in peripheral blood mononuclear cells of uremia patients
  

  Weiguo Sui¹, Qiang Yan², Huan Li^2,3, Juan Liu^2,3, Jiejing Chen², Liping Li^2,3, Yong Dai⁴

  (1) Nephrology Department, 181st Hospital, Guangxi Key Laboratory for Metabolic Diseases Research, Guilin, Guangxi - PR China
  (2) Nephrology Department of 181st Hospital, Guangxi Key Laboratory for Metabolic Diseases Research, Guilin, Guangxi - PR China
  (3) and College of Life Science, Guangxi Normal University, Guilin, Guangxi - PR China
  (4) Clinical Medical Research Center, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, Guangdong Province - PR China

• Progression of cardiac valve calcification and decline of renal function in CKD patients
  

  Luca Di Lullo¹, Alberto Santoboni¹, Vincenzo Barbera¹, Rodolfo Fernando Rivera², Luigi Morrone³, Domenico Russo⁴

  (1) Department of Nephrology and Dialysis, L. Parodi Delfino Hospital, Colleferro - Italy
  (2) Department of Nephrology, San Gerardo Hospital, Monza - Italy
  (3) Department of Nephrology, G. Rummo Hospital, Benevento - Italy
  (4) University of Naples, Napoli - Italy

• Prevalence of hypertension in a large cohort of Italian hemodialysis patients: results of a cross-sectional study
  

  Lucia Del Vecchio¹, Tiziano Lusenti², Goffredo Del Rosso³, Rosella Malandra³, Alessandro Balducci⁴, Attilio Losito⁵, Group for Arterial Hypertension of the Italian Society of Nephrology

  (1) Department of Nephrology and Dialysis, A. Manzoni Hospital, Lecco - Italy
  (2) Department of Nephrology and Dialysis, Santa Maria Nuova Hospital, Reggio Emilia - Italy
  (3) Department of Nephrology and Dialysis, Giuseppe Mazzini Hospital, Teramo - Italy
  (4) Department of Nephrology and Dialysis, S. Giovanni-Addolorata Hospital, Rome - Italy
  (5) Department of Nephrology and Dialysis, Santa Maria Della Misericordia Hospital, Perugia - Italy

• Epidemiology and mortality in dialysis patients with and without polycystic kidney disease: a national study in Taiwan
  

  Pei-Wen Lee¹, Chih-Chiang Chien^2,3,4, Wu-Chang Yang^1,5, Jhi-Joung Wang³, Chih-Ching Lin^1,5

  (1) Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei - Taiwan
  (2) Department of Nephrology, Chi-Mei Medical Center, Tainan - Taiwan
  (3) Department of Medical Research, Chi-Mei Medical Center, Tainan - Taiwan
  (4) and Department of Food Nutrition, Chung Hwa University of Medical Technology, Tainan - Taiwan
  (5) and School of Medicine, National Yang-Ming University, Taipei - Taiwan

• Ten-year patient survival on maintenance haemodialysis: association with treatment time and dialysis dose
  

  Seema Singh¹, Peter Choi¹, Albert Power¹, Damien Ashby¹, Thomas Cairns¹, Megan Griffith¹, Adam McLean¹, Andrew Palmer¹, David Taube¹, Neill Duncan¹

  (1) Imperial College Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London - UK

• Cerebral perfusion during intermittent hemodialysis in patients with acute kidney injury and advanced liver cirrhosis
  

  Giuseppe Regolisti¹, Umberto Maggiore¹, Carola Cademartiri¹, Aderville Cabassi¹, Alberto Caiazza², Santo Morabito³, Enrico Fiaccadori¹

  (1) Department of Internal Medicine, Nephrology and Health Sciences, University of Parma, Parma - Italy
  (2) Department of Internal Medicine and Diagnostics, Borgo Val di Taro, AUSL Parma, Parma - Italy
  (3) Division of Nephrology, Policlinico Umberto I, Rome - Italy

• N-Acetylcysteine in hemodialysis diabetic patients resets the activation of NF-kB in lymphomonocytes to normal values
  

  Alessandro Amore¹, Marco Formica², Franca Giacchino³, Graziella Gigliola², Franco Bonello³, Giovanni Conti¹, Roberta Camilla¹, Rosanna Coppo¹

  (1) Nephrology Dialysis Transplantation, Regina Margherita University Hospital, Torino - Italy
  (2) Nephrology and Dialysis, ASL Cuneo 1, Cuneo - Italy
  (3) Nephrology Dialysis Transplantation, Civic Hospital, Ivrea, Italy

• Variables associated with time of recovery after hemodialysis
  

  Maurizio Bossola¹, Enrico Di Stasio², Manuela Antocicco³, Patrizia Silvestri¹, Luigi Tazza¹

  (1) Hemodialysis Service, Department of Surgery, Catholic University, Rome - Italy
  (2) Department of Clinical Chemistry, Catholic University, Rome - Italy
  (3) Department of Geriatric, Catholic University, Rome - Italy

• Renal graft outcome in autosomal dominant medullary cystic kidney disease type 1
  

  Andreas P. Soloukides¹, Dimitrios-Anestis D. Moutzouris², Gregory N. Papagregoriou³, Christoforos V. Stavrou⁴, Constantinos C. Deltas³, Helen A. Tzanatos⁵

  (1) Nefrologiko Athinon Dialysis Center, Athens - Greece
  (2) Nephrology Department, Asklipieion General Hospital, Athens - Greece
  (3) Department of Biological Sciences, University of Cyprus, Nicosia - Cyprus
  (4) Evangelismos Hospital, Paphos - Cyprus
  (5) Nephrology Department, Aretaieion University Hospital, Athens - Greece

• Invasive assessment of renal artery atherosclerotic disease and resistant hypertension before renal sympathetic denervat
  

  Flavio Ribichini¹, Michele Pighi¹, Carlo Zivelonghi¹, Alessia Gambaro¹, Enrico Valvo¹, Antonio Lupo¹, Corrado Vassanelli¹

  (1) Department of Medicine, University of Verona, Verona - Italy

• Acid–base pathophysiology is not confusing, 
irrational and controversial
  

  Viktor Rosival¹

  (1) SYNLAB Department of Laboratory Medicine, Dérer’s Hospital, Bratislava - Slovakia

• Diabetic ketoacidosis does not cause coma when the arterial pH is above 6.9. Author’s reply to: Acid–base pathophysiolog
  

  Kenrick Berend¹

  (1) St. Elisabeth Hospital, Willemstad, Curacao - Netherlands Antilles